Updates are available Correction dated 2026-02-11
Click to view Correction: https://doi.org/10.1186/s40164-025-00735-3
-
Authors
Yan, Fangfang
Jiang, Vivian
Jordan, Alexa
Che, Yuxuan
Liu, Yang
Cai, Qingsong
Xue, Yu
Li, Yijing
McIntosh, Joseph
Chen, Zhihong
Vargas, Jovanny
Nie, Lei
Yao, Yixin
Lee, Heng-Huan
Wang, Wei
Bigcal, JohnNelson R.
Badillo, Maria
Meena, Jitendra
Flowers, Christopher
Zhou, Jia
Zhao, Zhongming
Simon, Lukas M.
Wang, Michael
-
Funding
Funding for this research was provided by:
NIH (R01LM012806)
CPRIT (RP180734)
MD Anderson B-cell Lymphoma Moon Shot Project
The Gary Rogers Foundation
Kinder Foundation
Cullen Foundation
start-up research funds by MD Anderson Cancer Center
NIH-funded Cancer Center Support Grant (P30 CA016672)
NIH Core Grant for the Sequencing and Microarray Facility (CA016672)
- License Information
-
More Information
Article History
Received: 9 October 2023
Accepted: 25 January 2024
First Online: 7 February 2024
Change Date: 11 February 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40164-025-00735-3
Declarations
:
: All patient samples were collected after obtaining written informed consent and approval from the Institutional Review Board at The University of Texas MD Anderson Cancer Center.
: Not applicable.
: MW is consultant to AstraZeneca, BeiGene, BioInvent, CSTone, Deciphera, DTRM Biopharma (Cayman) Limited, Epizyme, Genentech, InnoCare, Janssen, Juno Therapeutics, Kite Pharma, Lilly, Loxo Oncology, Miltenyi Biomedicine GmbH, Oncternal, Pepromene Bio, Pharmacyclics, VelosBio. MW has received research support from Acerta Pharma, AstraZeneca, BeiGene, BioInvent, Celgene, Genmab, Genentech, Innocare, Janssen, Juno Therapeutics, Kite Pharma, Lilly, Loxo Oncology, Molecular Templates, Oncternal, Pharmacyclics, VelosBio, Vincerx. MW received a speaker honoraria from Acerta Pharma, Anticancer Association, AstraZeneca, BeiGene, BGICS, BioInvent, CAHON, Clinical Care Options, Dava Oncology, Eastern Virginia Medical School, Epizyme, Hebei Cancer Prevention Federation, Imedex, Janssen, Kite Pharma, Leukemia & Lymphoma Society, LLC TS Oncology, Medscape, Meeting Minds Experts, Miltenyi Biomedicine GmbH, Moffit Cancer Center, Mumbai Hematology Group, OMI, OncLive, Pharmacyclics, Physicians Education Resources (PER), Practice Point Communications (PPC), The First Afflicted Hospital of Zhejiang University. ZZ is a consultant of Melax.
